Apellis Pharmaceuticals, Inc. | ||||
NMS : APLS || Location: United States | ||||
$48.72+1.08 (+2.27%) |
1.18 M | 47.97 - 50.0 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 28, 2024 | 10.440 M |
March 15, 2024 | 10.591 M |
Feb. 29, 2024 | 10.064 M |
Feb. 15, 2024 | 10.271 M |
Jan. 31, 2024 | 10.669 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.70 | -0.73 | -4.27% |
09/30/2023 | -0.87 | -1.17 | -34.08% |
06/30/2023 | -1.35 | -1.02 | 24.40% |
03/31/2023 | -1.49 | -1.56 | -4.46% |
12/31/2022 | -1.60 | -1.50 | 6.20% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 120.582M | Shares Float | 81.043M |
Short Float | 10.440M | Market Cap | 5874.76M |
Institution ownership | 96.02% | Insider ownership | 13.235% |
Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
Trailing EPS | -4.45 | Forward EPS | 1.20 |